Decreased Cortical Thickness Seen in Type 2 Diabetes

Share this content:
Decreased Cortical Thickness Seen in Type 2 Diabetes
Decreased Cortical Thickness Seen in Type 2 Diabetes

MONDAY, May 1, 2017 (HealthDay News) -- Patients with type 2 diabetes mellitus (T2DM) -- particularly those who are overweight or obese -- have decreased cortical thickness in several areas of the brain, according to research published online April 27 in Diabetologia.

The study included 50 overweight or obese patients with T2DM, 50 of normal-weight with T2DM, and 50 of normal-weight without T2DM. The Korean study volunteers were between 30 and 60 years old. Those with T2DM had it for five years or less, and they were prescribed lifestyle modifications and/or taking oral medication. All study participants underwent magnetic resonance imaging of the brain and cognitive testing.

The researchers found that global mean cortical thickness was lower in the overweight/obese T2DM group than in the normal-weight T2DM group. The team also observed a negative correlation between disease duration and global mean white matter integrity in the overweight/obese T2DM group, but not in the normal-weight T2DM group.

"This study showed that the concurrent presence of overweight/obesity was associated with cortical atrophy, disrupted white matter integrity, and cognitive dysfunction in early-stage type 2 diabetes," the authors write. "An increased awareness of overweight/obesity-related risk is necessary to prevent and manage type 2 diabetes-related brain atrophy and cognitive dysfunction from early-stage type 2 diabetes onward."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths